How Fe3+ binds anthracycline antitumour compounds: The myth and the reality of a chemical sphinx
- 15 June 1999
- journal article
- research article
- Published by Elsevier BV in Journal of Inorganic Biochemistry
- Vol. 75 (2), 105-115
- https://doi.org/10.1016/s0162-0134(99)00040-9
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The interactions of Fe3+ ions with adriamycin studied by 57Fe Mössbauer and electronic spectroscopiesJournal of Inorganic Biochemistry, 1997
- Evidence for polynuclear aggregates of ferric daunomycinEuropean Journal of Biochemistry, 1992
- Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol.Proceedings of the National Academy of Sciences of the United States of America, 1988
- Interaction of 5-iminodaunorubicin with Fe(III) and with cardiolipin-containing vesiclesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1986
- Physicochemical studies of the iron(III)-carminomycin complex and evidence of the lack of stimulated superoxide production by NADH deydrogenaseBiochimica et Biophysica Acta (BBA) - General Subjects, 1985
- Iron(III)-adriamycin and iron(III)-daunorubicin complexes: physicochemical characteristics, interaction with DNA, and antitumor activityBiochemistry, 1985
- Physicochemical characteristics of ferric adriamycin complexesCancer Chemotherapy and Pharmacology, 1984
- Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complexBiochemistry, 1982
- Speciation studies of adriamycin, quelamycin and their metal complexesInorganica Chimica Acta, 1980
- Quelamycin, a new derivative of adriamycin with several possible therapeutic advantagesEuropean Journal of Cancer (1965), 1978